Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice.
about
A commensal Helicobacter sp. of the rodent intestinal flora activates TLR2 and NOD1 responses in epithelial cellsManipulating the Gut Microbiota: Methods and ChallengesThe Intestinal Microbiota in Inflammatory Bowel DiseaseNutritional protective mechanisms against gut inflammationIntestinal microbiota composition of interleukin-10 deficient C57BL/6J mice and susceptibility to Helicobacter hepaticus-induced colitisA Multihit Model: Colitis Lessons from the Interleukin-10-deficient MouseGnotobiotic IL-10; NF-kappaB mice develop rapid and severe colitis following Campylobacter jejuni infection.Differing Complex Microbiota Alter Disease Severity of the IL-10-/- Mouse Model of Inflammatory Bowel Disease.Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation.Pseudomonas fluorescens encodes the Crohn's disease-associated I2 sequence and T-cell superantigenDistance burning: how gut microbes promote extraintestinal cancers.Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis.Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout miceT helper 1 and T helper 2 cells are pathogenic in an antigen-specific model of colitisInterleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans.The straw that stirs the drink: insight into the pathogenesis of inflammatory bowel disease revealed through the study of microflora-induced inflammation in genetically modified mice.Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone badMicrobial and histopathologic considerations in the use of mouse models of inflammatory bowel diseases.Helicobacter saguini, a Novel Helicobacter Isolated from Cotton-Top Tamarins with Ulcerative Colitis, Has Proinflammatory Properties and Induces Typhlocolitis and Dysplasia in Gnotobiotic IL-10-/- Mice.Nod2 is required for the regulation of commensal microbiota in the intestine.Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin-10-deficient mice.Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer.The effects of intestinal microbial community structure on disease manifestation in IL-10-/- mice infected with Helicobacter hepaticus.Role of the microbiota in inflammatory bowel diseases.The effects of commensal microbiota on immune cell subsets and inflammatory responses.The Microbiome in Visceral Medicine: Inflammatory Bowel Disease, Obesity and Beyond.Carcinogenesis and therapeutics: the microbiota perspective.Microbiota and reproducibility of rodent models.Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice.Endogenous antigen presenting cell-derived IL-10 inhibits T lymphocyte responses to commensal enteric bacteria.Antibiotics with a selective aerobic or anaerobic spectrum have different therapeutic activities in various regions of the colon in interleukin 10 gene deficient mice.Bacteria, inflammation, and colon cancer.Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment.Strain-specific colitis susceptibility in IL10-deficient mice depends on complex gut microbiota-host interactions.Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice.Natural colonization with Helicobacter species and the development of inflammatory bowel disease in interleukin-10-deficient mice.Lactobacillus reuteri promotes Helicobacter hepaticus-associated typhlocolitis in gnotobiotic B6.129P2-IL-10(tm1Cgn) (IL-10(-/-) ) mice.A gut pathobiont synergizes with the microbiota to instigate inflammatory disease marked by immunoreactivity against other symbionts but not itself.Bifidobacterium breve and Streptococcus thermophilus secretion products enhance T helper 1 immune response and intestinal barrier in mice.Epithelial barrier disruption allows nondisease-causing bacteria to initiate and sustain IBD in the IL-10 gene-deficient mouse.
P2860
Q21143791-E394A2A4-EA10-4357-B850-5DDBEDF9F045Q26795704-9681A385-09EB-4485-88CC-E4A13E218FD3Q26795705-7DE091AC-F4DC-4D49-B337-8ED0B5272089Q27028202-0FC9F18D-89B4-4BE5-B1C4-5279D8D818C3Q27310097-BAA6F36A-B3C6-4704-9B46-AED204A1721EQ28081920-0E8C5D3D-9429-461B-819A-1B537E1574F1Q33511448-6990C563-9ADA-41BC-BBB4-D990307A1D8FQ33658943-7DADF322-9C41-4E7E-BF95-ACB1BE200883Q34008033-6D581C06-973C-4496-9311-7341617E61CDQ34259452-4E2C1AB1-E705-4CD3-816C-597F73EC6FD6Q35577896-833C09BD-1211-4D33-9D92-F861D134F822Q35714248-DFF91C6A-908C-427F-ABCD-0AA7772BE7CBQ35747907-A1048A2E-B9B7-45B4-9806-C15E07A9D4F4Q36376495-3466B71D-49ED-4FF5-B23B-88B798EF321FQ36543665-9E194D56-6BF0-4007-8414-61BC482B7E91Q36715471-68BCA37D-E118-45AD-A225-17E67211A7B8Q37018335-BD6D4F40-E721-4C44-AEA5-943830F1B13BQ37070484-ED8E704E-EE3D-4513-B808-ECC50F23362CQ37129884-63D3CA35-66A0-452C-BDC3-404322EFCBA4Q37354181-50EBFDE3-A6D0-4608-903B-057BE3153279Q37394024-86999069-6311-4098-824B-66066B3FEC20Q37612291-88DB9177-9714-40DE-9314-33CA29F2F9E0Q37677374-C2FC2E45-396E-40D6-A16A-7689B4770429Q37936393-AF04DF7D-AAF3-4F77-A4A9-4720F1171D86Q37968293-227E2F14-A048-471C-8435-1D650F90151AQ38676932-1B12A7F8-7206-4D52-AD13-A4FB17B2D7F5Q39146396-684E7D58-211B-458C-B32C-46D22F7B3749Q39193387-9478041C-821F-41F1-BEC3-4FC9F2B2CC2EQ41395291-E13E39E9-9995-4916-B342-3F3D8C732543Q41963779-4F1F7A6A-3C34-4EF0-B75D-B08938328906Q42128973-C14B418A-E6B6-4F2A-9B4B-DF3C06F13C67Q42555752-27B5E8DE-A0F4-43C0-B590-9DD8947F9E0FQ43005855-1C2C75F8-A38E-4DE3-9410-1A01757F7632Q44097457-3E4386CF-012C-4C47-9C29-7E64737AC45BQ44596392-4BF897FF-3326-4E0B-B289-4ABABE70D6AFQ44954198-31EFC455-F175-448A-9A5D-BEB6A7B98F06Q45966062-B3143AC4-07BE-48E1-8440-774884C7D07FQ46237071-49A037B6-2655-4AC1-8C40-B8C6C100F92CQ46772268-1A894A0E-52FE-4323-B642-925030130E9BQ52578345-5F9E9F62-C9AA-4F62-AF78-5BA6B4A5A6D9
P2860
Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Helicobacter hepaticus does no ...... interleukin-10-deficient mice.
@en
Helicobacter hepaticus does no ...... interleukin-10-deficient mice.
@nl
type
label
Helicobacter hepaticus does no ...... interleukin-10-deficient mice.
@en
Helicobacter hepaticus does no ...... interleukin-10-deficient mice.
@nl
prefLabel
Helicobacter hepaticus does no ...... interleukin-10-deficient mice.
@en
Helicobacter hepaticus does no ...... interleukin-10-deficient mice.
@nl
P2093
P2860
P1476
Helicobacter hepaticus does no ...... interleukin-10-deficient mice.
@en
P2093
L A Dieleman
M S Goerres
R B Sartor
R K Sellon
S L Tonkonogy
W Grenther
P2860
P304
P356
10.1128/IAI.68.9.5107-5113.2000
P407
P577
2000-09-01T00:00:00Z